West Pharmaceutical Services Inc reports results for the quarter ended June 30 - Earnings Summary

West Pharmaceutical Services

24/07/2025 14:32

West Pharmaceutical Services Inc WST.N reported quarterly adjusted earnings of $1.84​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $1.52.  The mean expectation of fourteen analysts for the quarter was for earnings of $1.51 per share. Wall Street expected results to range from $1.43  to $1.54 per share.

Revenue rose 9.2% to $766.50 million from a year ago; analysts expected $727.45 million.

West Pharmaceutical Services Inc's reported EPS for the quarter was $1.82​.

The company reported quarterly net income of $131.8 million.

West Pharmaceutical Services Inc shares had risen by 3.9% this quarter and lost 30.6% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 1.4% in the last three months.​

In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for West Pharmaceutical Services Inc is $273.50, about 16.9% above its last closing price of $227.31

This summary was machine generated from LSEG data July 24 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
1.51
1.84
Beat
Mar. 31 2025
1.23
1.45
Beat
Dec. 31 2024
1.72
1.82
Beat
Sep. 30 2024
1.50
1.85
Beat